Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as a lyophilized powder for injection use. It provides combined FSH and LH activity to stimulate ovarian follicular development and estrogen production, and is employed in the treatment of infertility caused by anovulation and in ovarian stimulation for assisted reproductive technologies.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, fertility clinics and pharmacies worldwide, ensuring quality‑controlled product handling and regulatory compliance to global distribution.

Menopur, a gonadotropin used in reproductive endocrinology, is indicated for the following conditions:

Infertility due to anovulation: Facilitates follicular growth to enable ovulation and improve conception chances. Ovarian stimulation for assisted reproductive technology (IVF, ICSI): Enhances multiple follicle development to increase the number of retrievable oocytes. Induction of ovulation in hypogonadotropic hypogonadism: Replaces deficient endogenous gonadotropins to trigger ovulation in women with impaired hypothalamic‑pituitary function.

Menopur may cause a range of adverse reactions. Monitoring and prompt reporting are essential.

Common Side Effects: - Abdominal discomfort or bloating - Injection‑site pain, redness or swelling - Mild headache - Mild ovarian hyperstimulation syndrome (OHSS) presenting as mild abdominal distension - Nausea or mild vomiting

Serious or Rare Side Effects: - Severe OHSS with rapid weight gain, shortness of breath, or pleural effusion - Multiple pregnancy (twins, triplets, etc.) - Allergic reactions such as rash, urticaria, or anaphylaxis - Thromboembolic events - Ectopic pregnancy

Before initiating Menopur therapy, clinicians should consider several safety measures.

Monitor ovarian response: Use serial ultrasound and estradiol measurements to adjust dosing. Avoid use in active ovarian cysts: Presence of cysts increases risk of complications. Assess for hypersensitivity: Discontinue if allergic signs appear. Consider risk of multiple pregnancy: Counsel patients about the possibility of twins or higher-order gestations. Adjust dose in renal or hepatic impairment: Reduced clearance may heighten adverse effects. Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other agents that affect ovarian response or hemostasis.

Major Interactions (Avoid): - Concurrent use of other gonadotropins: May lead to excessive ovarian stimulation. - GnRH agonist therapy: Can amplify response and increase OHSS risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: May blunt the ovarian response to Menotropin. - Anticoagulants: Increased bleeding risk if ovarian cysts rupture. - Thyroid hormones: May alter hormone metabolism and affect treatment outcomes.